GPT-Rosalind suggests cholesterol transport as a potential target for neurodegeneration research

What happened

OpenAI reports that GPT-Rosalind proposed impaired cholesterol transport as a possible explanation for increased cholesterol synthesis gene expression after DCTN1 disruption in mouse-brain data. DCTN1 is linked to Perry syndrome, a rare neurodegenerative disorder. Working with @perturbai_tx and @scrippsresearch, thousands of GPT-Rosalind agents connected gene-expression results from millions of mouse brain cells with scientific literature in 32 minutes, yielding a mechanism scientists can test. https://openai.com/index/scaling-ai-research-for-complex-biological-data/

The story so far

OpenAI reported that GPT-Rosalind proposed impaired cholesterol transport as a possible explanation for gene-expression changes after DCTN1 disruption in mouse-brain data, producing a mechanism for scientists to test. DCTN1 is linked to Perry syndrome, a rare neurodegenerative disorder. Working with PerturbAI and Scripps Research, thousands of GPT-Rosalind agents connected gene-expression results from millions of mouse brain cells with scientific literature in 32 minutes, according to OpenAI. The analysis addressed increased expression of cholesterol synthesis genes after DCTN1 disruption. OpenAI framed the proposed mechanism as a drug-discovery lead, raising the question of whether restoring cholesterol transport could protect neurons from degeneration.

Keep reading

Trending now

1. 1Mistral and NVIDIA Announce Industrial Engineering AI Collaboration and Open Benchmarks
2. 2Mistral Releases Voxtral 3 Speech Models, Voice Agents API and LiveKit-Based SDK
3. 3DeepSeek Open-Sources DeepInfer and API Components, With Model and Hardware Limits
4. 4OpenAI Acquires Orchestra Bio to Add Drug Development Operations to Its Life Sciences Tools